Speaker
Description
Gastric cancer is the 5th most common cause of cancer-related deaths worldwide; in Europe, 5-year relative survival is under 40%. The European Commission (EC) has launched initiatives to improve the approach to cancer prevention, screening, and care, with the aim of overcoming service inequality across Europe. In 2025, EC selected The International Agency for Research on Cancer to provide the scientific and technical coordination of the EC’s newly launched Initiative on Gastric Cancer (EC-GaC) in collaboration with EC’s Joint Research Centre (JRC).
Because the majority of gastric cancer cases arise from Helicobacter pylori (Hp) infection, EC-GaC will initially focus on Hp screen-and-treat (S&T) as a primary prevention strategy. The objectives of EC-GaC are to develop evidence-based European guidelines on Hp S&T, and to conduct preparatory work for a future quality assurance scheme for relevant healthcare services. The guidelines will offer evidence-based recommendations and good practice statements on the implementation of S&T as organized, population-based programmes. Developed quality indicators will provide guidance for monitoring and evaluation of the recommendations.
EC-GaC is a person-centred initiative that will consider the needs of the users throughout all stages of the care pathway. While structure, organisation and delivery of services may vary across countries or regions, this initiative aims to provide sufficient flexibility to enable adaptation to all relevant contexts and health systems beyond Europe.